Page 74 - Critical Care Notes
P. 74

4223_Tab02_045-106  29/08/14  10:00 AM  Page 68



                  CV
          Management
          ■ Routine postoperative care: Maintain airway patency; monitor pulmonary
            status.
          ■ Monitor vital signs and intake and output.
          ■ Monitor dressing  and incision for drainage, erythema.
          ■ Perform peripheral and neurovascular assessments hourly for first 8 hr
            after surgery.
          ■ Monitor neurological status for first 8 hr postoperatively.
          ■ Titrate medications, vasopressors, and inotropes to optimize cardiac
            function and BP.
          ■ Monitor chest tube drainage.
          ■ Watch for signs of bleeding by monitoring Hgb and Hct every 4 hr.
          ■ Monitor for pain.
          ■ Start on anticoagulation therapy when approved by cardiac surgeon.
              Transcatheter Aortic Valve Replacement (TAVR)
          ■ TAVR was developed for the treatment of severe, symptomatic aortic stenosis,
            for patients at very high surgical risk for traditional valve replacement surgery,
            or for patients with technical issues with surgery (i.e., porcelain aorta or signif-
            icant mediastinal radiation).
          ■ Bilateral femoral arteries are prepped, the femoral artery is cannulated
            with a sheath, and the vessel is dilated. The sheath is replaced by a larger
            sheath, which is used to accommodate the stent-valve delivery system.
            An arterial catheter is placed in the left femoral artery for hemodynamic
            monitoring.
          ■ A guide wire and valvuloplasty balloon catheter are used to steer and
            deploy the stent-valve. Aortic balloon valvuloplasty is performed to sepa-
            rate the leaflets. Contrast is injected, and fluoroscopy is used to visualize
            the stent placement.
          ■ When the position of the stent-valve is confirmed, the device is then
            deployed. Rapid right ventricular pacing reduces cardiac wall motion and
            prevents the stent-valve from slipping from the correct position during bal-
            loon inflation. A temporary pacing lead is placed in the right ventricle via
            the femoral vein, and temporary pacing is initiated. This is followed by
            rapid inflation and deflation of the stent-deployment valvuloplasty balloon,
            and termination of pacing and a return of a normal rhythm.
          ■ Once the catheter is pulled back, the stent-valve will cover the native aortic
            leaflets and fit tightly in the aortic annulus. Angiography of the right and
            left coronary arteries is performed to assess blood flow. The femoral artery
            is repaired, and the sheath is removed.
          Pathophysiology
          Aortic stenosis. See under cardiac valve replacement
                                68
   69   70   71   72   73   74   75   76   77   78   79